Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Novo Nordisk A/S ADR | 17 | 1 | 1 | 0 | €119.50 | €130.44 | 9.153% |
| Abbott Laboratories | 16 | 0 | 2 | 0 | €97.22 | €116.81 | 20.148% |
| Natural Alternat. | 17 | 1 | 0 | 0 | €5.95 | - | - |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 3 | 0 | €38.00 | €84.74 | 123.011% |
| EyePoint Pharmaceuticals Inc. | 17 | 1 | 3 | 0 | €11.22 | €27.83 | 148.159% |
| Esperion Therapeutis.Inc. | 15 | 0 | 3 | 0 | €2.04 | €8.39 | 311.492% |
| Rhythm Pharmaceuticals | 15 | 0 | 2 | 0 | €35.60 | €45.98 | 29.157% |
| G1 Therapeutics | 15 | 1 | 3 | 0 | €4.44 | €10.56 | 137.922% |
| Stoke Therapeutics Inc | 15 | 1 | 3 | 0 | €11.10 | €21.00 | 89.222% |
| Bayer AG | 15 | 1 | 1 | 0 | €28.94 | €50.00 | 72.801% |
| Halozyme Therapeutics Inc. | 14 | 0 | 3 | 0 | €40.06 | €50.33 | 25.643% |
| MacroGenics Inc. | 14 | 0 | 5 | 1 | €3.07 | €14.25 | 363.696% |
| Repligen Corp. | 13 | 0 | 1 | 0 | €151.00 | €184.76 | 22.358% |
| Intellia Therapeutics Inc | 13 | 0 | 1 | 0 | €22.72 | €60.55 | 166.523% |
| Insmed Inc. | 14 | 1 | 3 | 0 | €24.00 | €43.04 | 79.343% |
| Akero Therapeutics Inc | 12 | 0 | 0 | 0 | €19.44 | €38.19 | 96.469% |
| Geron Corp. | 12 | 0 | 3 | 0 | €3.53 | €4.63 | 30.968% |
| Sanofi S.A. ADR | 11 | 0 | 0 | 0 | €45.80 | - | - |
| Catalyst Pharmaceutical Partners Inc | 11 | 0 | 1 | 0 | €14.80 | €24.13 | 63.117% |
| Gilead Sciences Inc | 12 | 1 | 5 | 0 | €61.21 | €86.77 | 41.760% |
| Teva Pharmaceutical Industries Ltd ADR | 12 | 1 | 1 | 1 | €15.10 | €17.65 | 16.856% |
| Corcept Therapeutics Inc. | 11 | 0 | 4 | 0 | €25.12 | €35.43 | 41.040% |
| Rigel Pharmaceutical Inc. | 10 | 0 | 1 | 0 | €0.92 | €13.77 | 1403.603% |
| Charles River Labs Intl | 10 | 0 | 1 | 0 | €212.20 | €248.57 | 17.139% |
| Biocryst Pharmaceuticals | 10 | 0 | 3 | 0 | €4.94 | €11.05 | 123.447% |